Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Jan;70(1):e30046.
doi: 10.1002/pbc.30046. Epub 2022 Nov 2.

Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease

Affiliations
Observational Study

Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease

Nitya Bakshi et al. Pediatr Blood Cancer. 2023 Jan.

Abstract

Introduction: There is limited understanding of pain, patient-reported outcomes (PROs) of health-related quality of life (HRQoL), psychological factors, and experimental pain sensitivity before and following hematopoietic cell transplant (HCT) in children with sickle cell disease (SCD).

Methods: Individuals aged 8 years and older, English speaking, and scheduled for a HCT were invited to participate in an observational study where they completed assessments of pain, PROs, psychological factors, and qualitative interviews before and around 3 months, 6 months, 1 year, and 2 years post-HCT. An optional substudy of experimental pain sensitivity before and around 6 month, 1 year, and 2 years post-HCT was also offered.

Results: Data from eight participants (median age 13.5 years, 25% female) with sickle cell anemia (SCA) or similarly severe genotype, and successful donor-derived erythropoiesis post-HCT are reported. We found that collection of pain, PROs, psychological factors, and qualitative data were feasible in the context of HCT. We found moderate to large differences in pain and some PROs between baseline to 1 year and baseline to 2 year post-HCT based on effect sizes, but only some differences were statistically significant. We found moderate to large differences in pressure pain threshold and moderate differences in cold pain threshold between baseline to 1 year and baseline to 2 year post-HCT based on effect sizes, but these differences were not statistically significant. Qualitative data indicated an improvement in pain and HRQoL post-HCT.

Conclusion: This study provides a framework for the conduct of multimodal pain assessments before and after HCT, which is feasible but faced with unique barriers.

Keywords: pain; patient-reported outcomes; pediatric hematology/oncology; quality of life; sickle cell disease; transplantation.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The author(s) declare that they have no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Trends in pain and PROs following HCT for SCD

References

    1. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and riskfactors. N Engl J Med. 1991;325:11–16. - PubMed
    1. Krishnamurti L Hematopoietic cell transplantation for sickle cell disease. Front Pediatr. 2020;8:551170. - PMC - PubMed
    1. Gluckman E, Cappelli B, Bernaudin F, et al. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood. 2017;129:1548–1556. - PMC - PubMed
    1. Bakshi N, Sinha CB, Ross D, Khemani K, Loewenstein G, Krishnamurti L. Proponent or collaborative: physician perspectives and approaches to disease modifying therapies in sickle cell disease. PLoS One. 2017;12:e0178413. - PMC - PubMed
    1. Hsieh MM, Fitzhugh CD, Weitzel RP, et al. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA. 2014;312:48–56. - PMC - PubMed

Publication types

LinkOut - more resources